The global in vitro diagnostics (IVD) market size is calculated at USD 102.05 billion in 2024, grew to USD 104.01 billion in 2025 and is predicted to surpass around USD 132.18 billion by 2034, expanding at a CAGR of 2.62% between 2024 and 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: In Vitro Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. In Vitro Diagnostics Market, by Product, 2024-2034
8.1.1. Reagents
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Instruments
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. In Vitro Diagnostics Market, by Test Location, 2024-2034
9.1.1. Point of Care
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Home Care
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Others
9.1.3.1. Market Revenue and Forecast (2021-2034)
10.1. In Vitro Diagnostics Market, by Technology, 2024-2034
10.1.1. Immunoassay
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Hematology
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Clinical Chemistry
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Molecular Diagnostics
10.1.4.1. Market Revenue and Forecast (2021-2034)
10.1.5. Coagulation
10.1.5.1. Market Revenue and Forecast (2021-2034)
10.1.6. Microbiology
10.1.6.1. Market Revenue and Forecast (2021-2034)
10.1.7. Others
10.1.7.1. Market Revenue and Forecast (2021-2034)
11.1. In Vitro Diagnostics Market, by Application, 2024-2034
11.1.1. Diabetes
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Cardiology
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Nephrology
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Infectious Disease
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Oncology
11.1.5.1. Market Revenue and Forecast (2021-2034)
11.1.6. Drug Testing
11.1.6.1. Market Revenue and Forecast (2021-2034)
11.1.7. Autoimmune Diseases
11.1.7.1. Market Revenue and Forecast (2021-2034)
11.1.8. Others
11.1.8.1. Market Revenue and Forecast (2021-2034)
12.1. In Vitro Diagnostics Market, by Others, 2024-2034
12.1.1. Standalone Laboratories
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Hospitals
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Academic & Medical Schools
12.1.3.1. Market Revenue and Forecast (2021-2034)
12.1.4. Point-of-Care
12.1.4.1. Market Revenue and Forecast (2021-2034)
12.1.5. Others
12.1.5.1. Market Revenue and Forecast (2021-2034)
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.1.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.4. Market Revenue and Forecast, by Application (2021-2034)
13.1.5. Market Revenue and Forecast, by Others (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.1.6.5. Market Revenue and Forecast, by Others (2021-2034)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2021-2034)
13.1.7.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.1.7.3. Market Revenue and Forecast, by Technology (2021-2034)
13.1.7.4. Market Revenue and Forecast, by Application (2021-2034)
13.1.7.5. Market Revenue and Forecast, by Others (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.2.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.4. Market Revenue and Forecast, by Application (2021-2034)
13.2.5. Market Revenue and Forecast, by Others (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.7. Market Revenue and Forecast, by Application (2021-2034)
13.2.8. Market Revenue and Forecast, by Others (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.10. Market Revenue and Forecast, by Application (2021-2034)
13.2.11. Market Revenue and Forecast, by Others (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Application (2021-2034)
13.2.13. Market Revenue and Forecast, by Others (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Product (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Technology (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Application (2021-2034)
13.2.15. Market Revenue and Forecast, by Others (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.3.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.5. Market Revenue and Forecast, by Others (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.7. Market Revenue and Forecast, by Others (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.9. Market Revenue and Forecast, by Others (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.10.5. Market Revenue and Forecast, by Others (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Technology (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Application (2021-2034)
13.3.11.5. Market Revenue and Forecast, by Others (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.4.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.5. Market Revenue and Forecast, by Others (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.7. Market Revenue and Forecast, by Others (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.9. Market Revenue and Forecast, by Others (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.10.5. Market Revenue and Forecast, by Others (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Product (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Technology (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Application (2021-2034)
13.4.11.5. Market Revenue and Forecast, by Others (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.5.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.4. Market Revenue and Forecast, by Application (2021-2034)
13.5.5. Market Revenue and Forecast, by Others (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Application (2021-2034)
13.5.7. Market Revenue and Forecast, by Others (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Product (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Test Location (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Technology (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Application (2021-2034)
13.5.8.5. Market Revenue and Forecast, by Others (2021-2034)
14.1. Alere, Inc.
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Hoffmann-La Roche Ltd.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Arkray
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Arkray
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Becton Disckinson
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Bio-Rad laboratories
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Danaher
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Sysmex Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Abbott Laboratories
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client